Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis

Jean-Christophe J.-C. Lagier (1, 2) , Matthieu Million (1, 2) , Philippe Gautret (2, 3) , Philippe Colson (1, 2) , Sébastien Cortaredona (2, 3) , Audrey Giraud-Gatineau (2, 3) , Stéphane Honoré (4) , Jean-Yves Gaubert (1, 2) , Pierre-Edouard Fournier (1, 2) , Hervé Tissot-Dupont (1, 2) , Eric Chabrière (1, 2) , Andreas Stein (1, 2) , Jean-Claude Deharo (5, 6) , Florence Fenollar (2, 3) , Jean-Marc Rolain (1, 2) , Yolande Obadia (2) , Alexis Jacquier (7) , Bernard La Scola (1, 2) , Philippe Brouqui (1, 2) , Michel Drancourt (1, 2) , Philippe Parola (2, 3) , Didier Raoult (1, 2) , Sophie Amrane (1, 2) , Camille Aubry (2) , Matthieu Bardou , Cyril Berenger , Laurence Camoin-Jau (1, 2) , Nadim Cassir (2) , Claire Decoster (2) , Catherine Dhiver (2) , Barbara Doudier (2) , Sophie Edouard (1, 2) , Stéphanie Gentile (2) , Katell Guillon-Lorvellec (1, 2) , Marie Hocquart (2) , Anthony Levasseur (1, 2) , Morgane Mailhe (2) , Isabelle Ravaux (2) , Magali Richez (2) , Yanis Roussel (1, 2) , Piseth Seng (2) , Christelle Tomei (2) , Christine Zandotti (2, 8)

1 MEPHI - Microbes évolution phylogénie et infections
2 IHU Marseille - Institut Hospitalier Universitaire Méditerranée Infection
3 VITROME - Vecteurs - Infections tropicales et méditerranéennes
4 APHM - Assistance Publique - Hôpitaux de Marseille
5 Service de cardiologie [Hôpital Nord - APHM]
6 C2VN - Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research
7 CRMBM - Centre de résonance magnétique biologique et médicale
8 UVE - Unité des Virus Emergents

Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre-including this research content-immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

Keywords: SARS-CoV-2; COVID-19; Hydroxychloroquine; Azithromycin

Domains: Life Sciences [q-bio]; Microbiology and Parasitology; Bacteriology; Life Sciences [q-bio]; Microbiology and Parasitology; Virology; Life Sciences [q-bio]; Microbiology and Parasitology; Parasitology; Life Sciences [q-bio]; Human health and pathology; Cardiology and cardiovascular system; Life Sciences [q-bio]; Human health and pathology; Emerging diseases; Life Sciences [q-bio]; Human health and pathology; Infectious diseases

Jean-Christophe J.-C. Lagier, Matthieu Million, Philippe Gautret, Philippe Colson, Sébastien Cortaredona, et al.. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Medicine and Infectious Disease, 2020, 36, pp.101791. ⟨10.1016/j.tmaid.2020.101791⟩. ⟨hal-03138793⟩